Page last updated: 2024-09-02

fingolimod hydrochloride and Severe Combined Immunodeficiency

fingolimod hydrochloride has been researched along with Severe Combined Immunodeficiency in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ahmed, A; Carol, HA; Ochfeld, EN	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Severe Combined Immunodeficiency

Article	Year
In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management. Immunologic research, 2022, Volume: 70, Issue:5 Topics: Actins; Azathioprine; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Infliximab; Lymphopenia; Mitogens; Neonatal Screening; Receptors, Antigen, T-Cell; Severe Combined Immunodeficiency; Vaccines	2022

Article

Year

In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management.

Immunologic research, 2022, Volume: 70, Issue:5

Topics: Actins; Azathioprine; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Infliximab; Lymphopenia; Mitogens; Neonatal Screening; Receptors, Antigen, T-Cell; Severe Combined Immunodeficiency; Vaccines

2022